From 26 till 29 June 2024: HIGHLIGHTS FROM ESMO GI
Your direct line with Munich
The 2024 ESMO Gastrointestinal Cancers Congress provides expert, multidisciplinary perspectives on the latest clinical and scientific advances in the field. Your Belgian colleagues are on site, or follow the program online, and keep you posted about the hottest topics as they happen. Stay tuned, and get ready for an exciting and informative journey!
Made possible with the financial support of AstraZeneca.
All videos are developed independently of the sponsors and are non-promotional.
Daily highlights
The TRANSMET study, initially presented at ASCO, provided new data on liver transplantation for patients with liver metastases from colorectal cancer. This randomised study included patients who had not experienced
Dr Willem Lybaert, a medical oncologist at VITAZ Sint-Niklaas and University Hospital Antwerp, provided a comprehensive review of pivotal studies presented during the Mini Oral Session 3 at the ESMO
At the recent ESMO Gastrointestinal Cancer Congress in Munich, five studies on colorectal cancer were presented in mini-oral session 2.
In mini-oral session one from ESMO GI 2024, the presentations were divided into three main sections. The first part focused on ctDNA analysis, the second broadly covered colorectal cancer and
In-depth stories
Dr Willem Lybaert, a medical oncologist affiliated with VITAZ Sint-Niklaas and University Hospital Antwerp, provides an extensive update on the TOPAZ-1 study.
The primary analysis of the TOPAZ-1 study demonstrated
Made possible with the financial support of AstraZeneca.
All videos are developed independently of the sponsors and are non-promotional.
